Denosumab Increases Risk of Emergently Treated Hypocalcemia in Advanced Chronic Kidney Disease

A target trial emulation evaluated the incidence of emergently treated hypoalcemia associated with denosumab by stage of chronic kidney disease (CKD) progression and presence of CKD-mineral and bone disorder (CKD-MBD). 

Read More